FDA Inspection
Robert Hayashi M.DRobert Hayashi M.D – FDA Inspection, Jul 8, 2022
Record Details
This FDA Inspection record concerns Robert Hayashi M.D, with an inspection on July 8, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Robert Hayashi M.D
- Inspection Date
- July 8, 2022
- Product Type
- Drugs
View Company Profile
ID · f9c98644-05c8-43bf-8742-19edc477c3e7
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1174496
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Robert Hayashi M.D
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 29, 2025 | Not classified | Kansas City District Office |
Other documents for Robert Hayashi M.D
- FDA Inspection 1281155 - 2025-08-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.